Browse by Author

Browse by Year

Browsing publications by Dr David Sheridan

Newcastle AuthorsTitleYearFull text
Emeritus Professor Margaret Bassendine
Dr Soren Nielsen
Dr Simon Bridge
Dr Daniel Felmlee
Dr David Sheridan
et al.
Hepatitis C virus and atherosclerosis: A legacy after virologic cure?2017
Dr Luca Miele
Dr David Sheridan
Diverse Impacts of the rs58542926 E167K Variant in TM6SF2 on Viral and Metabolic Liver Disease Phenotypes2016
Dr David Sheridan
FibroGENE: A gene-based model for staging liver fibrosis2016
Dr David Sheridan
Fiona Fenwick
Emeritus Professor Margaret Bassendine
Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection2016
Professor Quentin Anstee
Dr David Sheridan
Staging fibrosis and excluding advanced fibrosis in patients with NAFLD: comparison of non-invasive markers in an interim analysis from a prospective multicentre study2016
Dr David Sheridan
Professor Margaret Bassendine
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease2015
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Dr R Neely
Emeritus Professor Margaret Bassendine
et al.
Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency2014
Dr David Sheridan
Emeritus Professor Margaret Bassendine
Hepatitis C lipoviral particle levels are associated with spontaneous clearance of acute infection2014
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Fiona Fenwick
Dr R Neely
et al.
Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial2014
Professor Margaret Bassendine
Dr David Sheridan
Jaime Jonsson
CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection2013
1234